Medication Administration Errors During Pass
Summary
The facility failed to maintain a medication error rate of less than 5% during medication pass, and the survey identified a 10.34% medication error rate involving two sampled residents. One error involved a resident with diagnoses including unspecified atrial fibrillation, hemiplegia, hemiparesis following cerebral infarction, and long-term anticoagulant use. During a medication pass, an LVN prepared aspirin 81 mg from a manufacturer bottle that did not have an expiration date visible. The LVN stated he could not find the expiration date on the bottle and planned to check the medication room after the pass, but he continued administering the aspirin along with the resident’s other medications. The resident’s order summary showed aspirin EC 81 mg daily for CVA prevention. The DON stated the aspirin bottle should have been replaced because it did not show an expiration date. A second resident with diagnoses including idiopathic peripheral autonomic neuropathy, ptosis, blepharochalasis, cataract, and varicose veins with pain was observed during medication administration by another LVN. The LVN entered the room with a blood pressure monitor and stated she did not need to check the resident’s BP because the resident was not on antihypertensive medications, and she planned to check vital signs later in the shift. The resident’s medication pass included gabapentin 100 mg with an order to hold for RR less than 12. The MAR documented gabapentin as administered even though the RR was recorded as 9 at the time of administration. During interview, the LVN stated she should have checked the RR before giving gabapentin and acknowledged that the medication should not have been administered if RR was less than 12. The same resident also had an order for omega-3 oral capsule 500 mg listed as [NAME] oil, but the medication pass included fish oil instead. The LVN stated she was not sure of the difference between fish oil and [NAME] oil and stated the facility would need to call the physician before changing medications. The DON stated nurses should check vital signs first when orders include parameters and stated that if RR was not checked as ordered, gabapentin could have caused respiratory depression and shortness of breath. The facility’s therapeutic interchange form listed omega-3 fatty acid interchanges such as Lovaza and Vascepa, but it did not list fish oil and [NAME] oil.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.